JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.89% |
| 2 | Financials | 12.24% |
| 3 | Healthcare | 8.95% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Magnachip Semiconductor
MX
$137M
| $2.07M | ﹤0.01% |
204,262
+8,662
| +4% | +$91.1K |
|
|
DBD
3252
DELISTED
Diebold Nixdorf Incorporated
DBD
| $2.07M | ﹤0.01% |
184,764
+5,343
| +3% | +$63.3K |
|
3253
Karyopharm Therapeutics
KPTI
$45.1M
| $2.06M | ﹤0.01% |
14,314
+630
| +5% | +$85.4K |
|
3254
Commercial Vehicle Group
CVGI
$130M
| $2.06M | ﹤0.01% |
285,058
+6,115
| +2% | +$44.8K |
|
3255
AnaptysBio
ANAB
$1.66B
| $2.05M | ﹤0.01% |
58,542
+2,470
| +4% | +$118K |
|
3256
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $2.05M | ﹤0.01% |
23,270
+6,887
| +42% | +$602K |
|
|
TARO
3257
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2.05M | ﹤0.01% |
27,125
+4,498
| +20% | +$365K |
|
3258
Plexus
PLXS
$7.25B
| $2.04M | ﹤0.01% |
32,724
-1,211
| -4% | -$71.8K |
|
3259
Spok Holdings
SPOK
$230M
| $2.04M | ﹤0.01% |
171,285
+107,263
| +168% | +$1.39M |
|
|
LVGO
3260
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $2.04M | ﹤0.01% |
+117,104
| New | +$3.54M |
|
3261
PUT
Roku
ROKU
$22.9B
| $2.04M | ﹤0.01% |
+20,000
| New | +$2.45M |
|
3262
iShares US Financial Services ETF
IYG
$2.24B
| $2.03M | ﹤0.01% |
44,730
+16,287
| +57% | +$734K |
|
3263
Enphase Energy
ENPH
$5.39B
| $2.03M | ﹤0.01% |
91,478
-169
| -0.2% | -$4.33K |
|
|
BMTC
3264
DELISTED
Bryn Mawr Bank Corp
BMTC
| $2.03M | ﹤0.01% |
55,612
+3,798
| +7% | +$137K |
|
|
NGD
3265
DELISTED
New Gold Inc
NGD
| $2.03M | ﹤0.01% |
2,008,097
-329,937
| -14% | -$401K |
|
3266
iShares US Utilities ETF
IDU
$1.38B
| $2.03M | ﹤0.01% |
24,890
+238
| +1% | +$18.5K |
|
3267
Sanofi
SNY
$105B
| $2.02M | ﹤0.01% |
43,481
+10,010
| +30% | +$432K |
|
|
ACHN
3268
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.01M | ﹤0.01% |
559,312
-130,257
| -19% | -$502K |
|
3269
Matsons
MATX
$6.41B
| $2.01M | ﹤0.01% |
53,645
+15,767
| +42% | +$599K |
|
|
AKRX
3270
DELISTED
Akorn Inc
AKRX
| $2.01M | ﹤0.01% |
529,364
-808,480
| -60% | -$2.89M |
|
3271
Innoviva
INVA
$1.5B
| $2M | ﹤0.01% |
190,104
+16,104
| +9% | +$193K |
|
3272
CALL
Nektar Therapeutics
NKTR
$2.57B
| $2M | ﹤0.01% |
7,333
+3,333
| +83% | +$1.22M |
|
3273
Under Armour Class C
UA
$2.25B
| $2M | ﹤0.01% |
110,540
+12,061
| +12% | +$238K |
|
|
BNY
3274
PUT
Bank of New York Mellon
BNY
$110B
| $2M | ﹤0.01% |
44,300
| – | – |
|
3275
Pearson
PSO
$9.78B
| $2M | ﹤0.01% |
221,404
+214,301
| +3,017% | +$2.22M |
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,787 increased, 1,863 reduced and 427 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 427 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.